TERN
Price:
$7.81
Market Cap:
$549.60M
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase Ib clinical trial for the treatment of NASH. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and TERN-601, a smal...[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
TERN
According to Terns Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 21.02. This represents a change of -10.22% compared to the average of 23.41 of the last 4 quarters.
The mean historical Current Ratio of Terns Pharmaceuticals, Inc. over the last ten years is 21.04. The current 21.02 Current Ratio has changed 9.89% with respect to the historical average. Over the past ten years (40 quarters), TERN's Current Ratio was at its highest in in the December 2022 quarter at 33.68. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
21.04
Median
23.43
Minimum
3.98
Maximum
37.25
Discovering the peaks and valleys of Terns Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 514.71%
Maximum Annual Current Ratio = 37.25
Minimum Annual Increase = -87.95%
Minimum Annual Current Ratio = 3.98
Year | Current Ratio | Change |
---|---|---|
2023 | 22.39 | -33.52% |
2022 | 33.68 | 37.59% |
2021 | 24.48 | 514.71% |
2020 | 3.98 | -11.31% |
2019 | 4.49 | -87.95% |
The current Current Ratio of Terns Pharmaceuticals, Inc. (TERN) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
26.85
5-year avg
17.80
10-year avg
21.04
Terns Pharmaceuticals, Inc.’s Current Ratio is greater than Amylyx Pharmaceuticals, Inc. (4.66), greater than Acumen Pharmaceuticals, Inc. (17.37), greater than Inozyme Pharma, Inc. (9.84), greater than X4 Pharmaceuticals, Inc. (6.07), greater than Mereo BioPharma Group plc (6.07), greater than PDS Biotechnology Corporation (3.84), greater than HOOKIPA Pharma Inc. (3.86), greater than Day One Biopharmaceuticals, Inc. (4.09), greater than Eledon Pharmaceuticals, Inc. (14.48),
Company | Current Ratio | Market cap |
---|---|---|
4.66 | $161.36M | |
17.37 | $133.38M | |
9.84 | $312.42M | |
6.07 | $109.78M | |
6.07 | $664.26M | |
3.84 | $107.88M | |
3.86 | $159.50M | |
4.09 | $1.25B | |
14.48 | $100.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Terns Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Terns Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Terns Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for Terns Pharmaceuticals, Inc. (TERN)?
What is the highest Current Ratio for Terns Pharmaceuticals, Inc. (TERN)?
What is the 3-year average Current Ratio for Terns Pharmaceuticals, Inc. (TERN)?
What is the 5-year average Current Ratio for Terns Pharmaceuticals, Inc. (TERN)?
How does the current Current Ratio for Terns Pharmaceuticals, Inc. (TERN) compare to its historical average?